HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Josep Maria Cruzado Selected Research

HLA-D Antigens

7/2021Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
1/2021HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Josep Maria Cruzado Research Topics

Disease

3Inflammation (Inflammations)
07/2021 - 01/2017
2Infections
06/2022 - 01/2022
2Albuminuria
01/2022 - 06/2021
2Chronic Renal Insufficiency
01/2022 - 02/2019
2Membranous Glomerulonephritis (Membranous Nephropathy)
07/2021 - 01/2021
2Proteinuria
06/2021 - 11/2015
2Septic Shock (Toxic Shock Syndrome)
03/2015 - 11/2013
2Bacteremia
03/2015 - 11/2013
1COVID-19
01/2022
1Diabetes Mellitus
01/2022
1IGA Glomerulonephritis (IGA Nephropathy)
01/2022
1Kidney Diseases (Kidney Disease)
01/2022
1Acute Tubulointerstitial Nephritis
07/2021
1Necrosis
07/2021
1Disease Progression
06/2021
1Lupus Nephritis
06/2021
1Disease Susceptibility (Diathesis)
01/2021
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2019
1Hypotension (Low Blood Pressure)
02/2018
1Anemia
02/2018
1Neoplasms (Cancer)
01/2017
1Ureteral Obstruction
01/2017
1Fibrosis (Cirrhosis)
01/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017
1Vasculitis (Vasculitides)
08/2016
1Delayed Graft Function
11/2015
1Renal Insufficiency (Renal Failure)
10/2014
1Chronic Disease (Chronic Diseases)
09/2012

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2022 - 01/2020
3Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 11/2013
2CreatinineIBA
01/2022 - 09/2012
2Biomarkers (Surrogate Marker)IBA
07/2021 - 08/2016
2HLA-D AntigensIBA
07/2021 - 01/2021
2AntibodiesIBA
06/2021 - 11/2019
2Pharmaceutical PreparationsIBA
03/2015 - 11/2013
1SymportersIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Metformin (Glucophage)FDA LinkGeneric
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1SodiumIBA
01/2022
1VaccinesIBA
01/2022
1Interleukin-12 (IL 12)IBA
01/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2021
1Antigen-Antibody Complex (Immune Complex)IBA
06/2021
1Carrier Proteins (Binding Protein)IBA
01/2020
1Myeloblastin (Proteinase 3)IBA
11/2019
1Peroxidase (Myeloperoxidase)IBA
11/2019
1Calcineurin InhibitorsIBA
01/2017
1EnzymesIBA
01/2017
1TOR Serine-Threonine KinasesIBA
01/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1AntigensIBA
01/2017
1MTOR InhibitorsIBA
01/2017
1Tacrolimus (Prograf)FDA LinkGeneric
11/2015
1QuinolonesIBA
11/2013
1LactamsIBA
11/2013
1VancomycinFDA LinkGeneric
11/2013
1Carbapenems (Carbapenem Antibiotics)IBA
11/2013

Therapy/Procedure

6Therapeutics
01/2022 - 11/2013
6Transplantation
01/2022 - 11/2013
3Kidney Transplantation
01/2022 - 01/2017
1Organ Transplantation
01/2022
1Renal Dialysis (Hemodialysis)
02/2018
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2017
1Liver Transplantation
10/2014